116 related articles for article (PubMed ID: 4584486)
1. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
[No Abstract] [Full Text] [Related]
2. Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
Lippman AJ; Helson C; Helson L; Krakoff IH
Cancer Chemother Rep; 1973 Apr; 57(2):191-200. PubMed ID: 4126381
[No Abstract] [Full Text] [Related]
3. Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
Higby DJ; Wallace HJ; Holland JF
Cancer Chemother Rep; 1973; 57(4):459-63. PubMed ID: 4586953
[No Abstract] [Full Text] [Related]
4. Cis-diamminedichloroplatinum (II). A new anticancer drug.
Rozencweig M; von Hoff DD; Slavik M; Muggia FM
Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117
[TBL] [Abstract][Full Text] [Related]
5. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
6. Clinical trial of cisplatin and intensive course 5-fluorouracil for the treatment of advanced colorectal cancer.
O'Connell MJ; Moertel CG; Kvols LK; Hahn RG; Rubin J
Am J Clin Oncol; 1986 Jun; 9(3):192-5. PubMed ID: 3524189
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
Rubin J; Sorensen S; Schutt AJ; van Hazel GA; O'Connell MJ; Moertel CG
Am J Clin Oncol; 1983 Jun; 6(3):325-6. PubMed ID: 6846250
[No Abstract] [Full Text] [Related]
8. High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: a Southeastern Cancer Study Group trial.
DeSimone PA; Davila E; Jochimsen PR; Bartolucci AA
Cancer Treat Rep; 1986 Oct; 70(10):1229-30. PubMed ID: 3530449
[No Abstract] [Full Text] [Related]
9. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
10. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
13. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
[No Abstract] [Full Text] [Related]
15. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
Fink DJ; Foye LV
Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
[No Abstract] [Full Text] [Related]
16. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
Talley RW; O'Bryan RM; Gutterman JU; Brownlee RW; McCredie KB
Cancer Chemother Rep; 1973; 57(4):465-71. PubMed ID: 4762440
[No Abstract] [Full Text] [Related]
17. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
von Eyben FE; Larsen V; Pedersen H
Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
[No Abstract] [Full Text] [Related]
19. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
Cantrell JE; Hart RD; Taylor RF; Harvey JH
Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
